Insight Genetics Inc

We are a molecular diagnostics company that is working to enhance the diagnosis, monitoring and treatment of cancer.

[Insight Genetics Inc @InsightGenetics]

"We believe Insight TNBCtype can further enable clinical trial testing and ultimately become the standard of care for TNBC patients bringing TNBC into the age of precision medicine.” - Eric Dahlhauser, Insight Genetics CEO https://t.co/5yJ7eGfOvZ

[Insight Genetics Inc @InsightGenetics]

Did you know molecular profiling is integral to developing treatments for #TNBC? Learn more about triple negative breast cancer here: https://t.co/togZvSwwiM #moleculardiagnostics #breastcancer #precisionmedicine

[Insight Genetics Inc @InsightGenetics]

Identifying #TNBC biomarkers can advance targeted drug development. Insight TNBCtype categorizes TNBC tumors into molecular subtypes. https://t.co/IvF7sklhZA #targetedtherapies #breastcancer

[Insight Genetics Inc @InsightGenetics]

Thank you @SABCSSanAntonio for a wonderful conference highlighting some of the most important work in cancer diagnostics and treatment. Already looking forward to 2019! #SABCS18 #breastcancer #bcsm #TNBC

[Insight Genetics Inc @InsightGenetics]

Thanks Dr. Sharma from @KUMedCenter for explaining the longterm outcomes of #TNBC for adjuvant AC chemotherapy patients. #SABCS18 #bcsm https://t.co/lWVLtBtNV3

[Insight Genetics Inc @InsightGenetics]

Important insight from Dr. Musuda from @MDAndersonNews on #TNBC tumor samples at #SABCS18. https://t.co/lWVLtBtNV3

[Insight Genetics Inc @InsightGenetics]

Check out Poster #P4-08-06 on the impact of molecular subtypes on long-term outcomes in #TNBC patients treated with adjuvant AC #chemotherapy #SABCS18 #TNBC #targetedtherapies #bcsm

[Triple Negative Breast Cancer Foundation @TNBCFoundation]

The @TNBCFoundation hosted a meeting at the San Antonio Breast Cancer Symposium dedicated exclusively to TNBC. An update from the #SABCS is now available online for our TNBC community. Read more at: https://t.co/HB1XQ2qQf6

[Insight Genetics Inc @InsightGenetics]

Check out abstracts #P4-02-05 and #P4-08-06 about #TNBC at tomorrow's Poster Sessions from 7-9 am in Hall 1! #SABCS18 #bcsm

[Insight Genetics Inc @InsightGenetics]

Are you at #SABCS18? Come to Poster Session 4 on 12/7 to learn how we're advancing #TNBC diagnostics and therapeutics

[Insight Genetics Inc @InsightGenetics]

In many ways, #TNBC is the last frontier in breast cancer, as there are currently no targeted therapeutics available for this population. We’re working to change that with Insight TNBCtype™. https://t.co/IvF7sklhZA #targetedtherapy #precisionmedicine https://t.co/lWVLtBtNV3

[Insight Genetics Inc @InsightGenetics]

@teamoncology about Insight TNBCtype - “The opportunity to improve the treatment and lives of TNBC patients with a diagnostic that is CLIA-validated and commercially positioned to support clinical trials is a major step forward.” #TNBC #cancerdiagnostics https://t.co/5yJ7eGfOvZ

[Insight Genetics Inc @InsightGenetics]

Excited for the #SABC18 Poster Session 4 on Friday. Insight TNBCtype will be included in two posters - one from @KUMedCenter and one from @MDAndersonNews. #bcsm #targetedtherapies #TNBC

[Insight Genetics Inc @InsightGenetics]

Insight TNBCtype has the potenial to accelerate #clinicalresearch and advance #targetedtherapies for triple negative breast cancer. #TNBC #bcsm https://t.co/IvF7sklhZA

[SWOG Cancer Research Network @SWOG]

@SWOG investigators present three breast cancer studies at #SABCS18. Public-powered cancer research! @theNCI #BeatCancerWithResearch https://t.co/iTTuaIJjqC via @SWOG @EurekAlert

[Insight Genetics Inc @InsightGenetics]

We're following @MedscapeOnc for regular news updates from #SABC18. #bcsm #oncology https://t.co/Kg5nv5ASzC

[Julie Gralow @jrgralow]

Up next - our session on late recurrence in ER+ breast cancer - w/ M Ellis, M Dowsett, L Chodash #SABCS18

[Insight Genetics Inc @InsightGenetics]

We are dedicated to improving the lives of cancer patients through advanced molecular diagnostics that enable precision cancer care. We're ready for this year's #SABCS18! #precisionmedicine #bcsm #TNBC

[Insight Genetics Inc @InsightGenetics]

Insight TNBCtype is a new test that categorizes triple negative breast cancer tumors into distinct molecular subtypes. #breastcancer #bcsm #TNBC https://t.co/IvF7sklhZA

[Insight Genetics Inc @InsightGenetics]

Insight Genetic contributed to two posters at #SABCS18 that showcase findings from the use of Insight TNBCtype! Stop by poster session #4 on Friday! #TNBC #bcsm